Atlas Trials

Pharmacokinetic Model of Abemaciclib: Correlation With Severe Diarrhea as the Primary Toxicity Endpoint in Patients With Localized Hormone Receptor-positive Breast Cancer

Clinical trial NCT07490509 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07490509
Sponsor
Poitiers University Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
AbemaciclibAbemaciclib-related DiarrheaBreast Cancer
Start date
2026-09-01
Primary completion
2029-09-01
Enrollment
235

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.